The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction.

Rizvi, Ali A; Rizzo, Manfredi

Rizvi, Ali A; Rizzo, Manfredi.

Afiliación

Rizvi AA; Department of Medicine, University of Central Florida College of Medicine, Orlando, Florida, USA.
Rizzo M; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Promise), University of Palermo, Palermo, Italy.

Diabetes Metab Syndr Obes ; 15: 1023-1030, 2022.

Article en En | MEDLINE | ID: mdl-35411165

Palabras clave

glucagon-like peptide-1; glucose-dependent insulinotropic polypeptide; incretins; type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Diabetes Metab Syndr Obes Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google